336 results on '"Abraham, William T."'
Search Results
2. In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial
3. Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)
4. Heart Failure and Respiratory Hospitalizations Are Reduced in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease With the Use of an Implantable Pulmonary Artery Pressure Monitoring Device
5. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation in Patients With Moderately Reduced Left Ventricular Ejection Fraction and a Narrow QRS Duration: Study Rationale and Design
6. Sleep-Disordered Breathing in Heart Failure: Identifying and Treating an Important but Often Unrecognized Comorbidity in Heart Failure Patients
7. Prognostic Impact of the Addition of Ventilatory Efficiency to the Seattle Heart Failure Model in Patients With Heart Failure
8. Prospective Evaluation of Elastic Restraint to Lessen the Effects of Heart Failure (PEERLESS-HF) Trial
9. A Novel Approach Using Remote Speech Analysis In Chronic Ambulatory Heart Failure Patients Allows Early Detection Of Clinical Decompensation Leading To Hospitalization Or Unplanned Iv Diuretics Treatment - Updated New Data
10. Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure
11. Improved Algorithm to Detect Fluid Accumulation via Intrathoracic Impedance Monitoring in Heart Failure Patients With Implantable Devices
12. Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction
13. Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 2—Use in Automated Detection
14. Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 1—Insights into Pathophysiology
15. CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System
16. In-hospital Testing for Sleep-disordered Breathing in Hospitalized Patients With Decompensated Heart Failure: Report of Prevalence and Patient Characteristics
17. The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network
18. Application of Implantable Hemodynamic Monitoring in the Management of Patients With Diastolic Heart Failure: A Subgroup Analysis of the COMPASS-HF Trial
19. Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate
20. Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HF
21. Rationale, Design, and Methods for a Pivotal Randomized Clinical Trial of Continuous Aortic Flow Augmentation in Patients With Exacerbation of Heart Failure: The MOMENTUM Trial
22. Effect of Cardiac Resynchronization Therapy on Myocardial Gene Expression in Patients with Nonischemic Dilated Cardiomyopathy
23. Predictors of Delivery of Hospital-Based Heart Failure Patient Education: A Report from OPTIMIZE-HF
24. Kidney Function After Initiation And Discontinuation Of Empagliflozin (EMPA) In Heart Failure (HF) Patients (Pts) With And Without Type 2 Diabetes (T2D): Insights From The Emperial Trials
25. Noninvasive Calibration of Cardiac Pressure Transducers in Patients With Heart Failure: An Aid to Implantable Hemodynamic Monitoring and Therapeutic Guidance
26. Predictors of Remodeling in the CRT Era: Influence of Mitral Regurgitation, BNP, and Gender
27. A Novel Approach Using Remote Speech Analysis in Chronic Ambulatory Heart Failure Patients Allows Early Detection of Clinical Decompensation Leading to Hospitalization
28. Canine Nonischemic Left Ventricular Dysfunction: A Model of Chronic Human Cardiomyopathy
29. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients
30. Primary Results of the Sensible Medical Innovations Lung Fluid Status Monitor Allows Reducing Readmission Rate of Heart Failure Patients (smile) Trial
31. V-LAP Left Atrial Monitoring systEm for Patients with Chronic sysTOlic and Diastolic Congestive Heart FailuRe First-in-Human
32. Predicting response to carvedilol for the treatment of heart failure: A multivariate retrospective analysis
33. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE)
34. New developments in heart failure: Role of endothelin and the use of endothelin receptor antagonists
35. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE)
36. Preceptorships: A practical approach to education in heart failure
37. Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure
38. Front-Loaded Intervention during First 90 Days of Pulmonary Pressure Guided Management
39. Hemodynamic Monitoring in Advanced Heart Failure: Results from the LAPTOP-HF Trial
40. Benefit of Longitudinal Pulmonary Artery Pressure Monitoring to Reduce Heart Failure Hospitalization Extends to Obese Patients
41. Economic Impact of Hemodynamic Monitoring in Heart Failure Patients: Estimating the Number-Needed-to-Treat and the Break-Even-Point Using a Claims Database
42. Pulmonary Artery Pressures Decrease Over Time during Heart Failure Management Guided by Ambulatory Hemodynamic Monitoring in Real World Setting
43. Percutaneous Ventricular Restoration (PVR) therapy using the Parachute® Device in Subjects with Ischemic Dilated Heart Failure: Two Year Meta-Analysis
44. Remote Dielectric Sensing (ReDS™)-Guided Patient Management of Ambulatory Heart Failure Patients Reduces Rehospitalization Rates
45. Pulmonary Artery Pressure Guided Heart Failure Management During a ‘Real-World’ Clinical Setting Follow-Up Period Demonstrated Even Greater Improvement in Clinical Outcomes Than That Achieved in the CHAMPION Randomized Controlled Trial
46. Impact of Pulmonary Artery Pressure Monitoring on All-cause 30-day HF Readmissions and Associated Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program Penalty
47. Benefits of Pulmonary Artery Pressure Monitoring in Patients with NYHA Class III Heart Failure and Chronic Kidney Disease: Results from the CHAMPION Trial
48. Changes in Thoracic Impedance Measured via the Azygos Vein with the remedē® System Indicate Worsening Heart Failure
49. “Responder Analysis” for Assessing Effectiveness of Heart Failure Therapies Based on Measures of Exercise Tolerance
50. 250 - Economic Impact of Hemodynamic Monitoring in Heart Failure Patients: Estimating the Number-Needed-to-Treat and the Break-Even-Point Using a Claims Database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.